GHK-Cu : A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that stimulates wound healing, collagen synthesis, and hair growth
2015 Jul 2 [cited 2018 Oct 17];373(1):1122
Adam Taylor, Professor of Anatomy, Lancaster University This article is republished from The Conversation under a Creative Commons license
The only circumstances where compounding semaglutide or tirzepatide may be permissible are: True allergy to a specific inactive ingredient in the FDA-approved version, documented with allergy testing and medical records Documented medical need for a different concentration not commercially available, with clear clinical justification Specific patient population requiring dosage form modification , such as pediatric use with proper medical justification Healthcare providers must document medical necessity with extensive clinical evidence
Ethical Approval The study protocol was approved by the Ethical Review Board at each site (Supplementary Material Table 1), including the Ethical Review Board at the Principal Investigator site (Advarra Inc., Columbia, Maryland, US)
Synthesis and applications of cyclopeptides and depsipeptides